Tyvaso 80 MCG
Ended Awarded Last action
- Contract number
- 36C24526N0466
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $33,158
Award facts
- Contract value 100% obligated
- $33,158.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs Veterans Integrated Service Network 5 (VISN 5) awarded a $33,158.10 firm fixed-price delivery order to United Therapeutics Corp for Tyvaso 80 micrograms on April 3, 2026, with an ultimate completion date of April 10, 2026. Tyvaso (treprostinil) is a specialized inhalation solution used to treat pulmonary arterial hypertension in veterans. This delivery order was issued without a set-aside designation under the General Services Administration's Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB) contract vehicle.
This award represents a single delivery order executed under United Therapeutics' broader $207.1 million blanket purchase agreement with the VA National Acquisition Center, which provides a streamlined procurement mechanism for four critical pharmaceutical products: Unituxin, Remodulin, Tyvaso, and Orenitram. As a single-award BPA, all orders flow directly to United Therapeutics without competition, enabling VISNs nationwide to procure these specialized medications at pre-negotiated prices. United Therapeutics, a biotechnology manufacturer headquartered in Silver Spring, Maryland, is registered as a self-certified small disadvantaged business and serves as a significant supplier of life-saving treatments to the VA system across multiple regions.
Quick answers
Who was awarded contract 36C24526N0466?
36C24526N0466 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 5 (Veterans Health Administration) on April 3, 2026.
How much is contract 36C24526N0466 worth?
The government has obligated $33,158 on 36C24526N0466.
Is contract 36C24526N0466 an order under another contract?
Yes. 36C24526N0466 is a delivery order under 36F79720D0104, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0466 competed?
The extent of competition for 36C24526N0466 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award